Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care patients and lacks effective treatments. A previous randomised controlled Phase II trial suggested that an intravenous (i.v.) infusion of salbutamol may be beneficial, as it reduced extravascular lung water an...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Gates, S, Perkins, G, Lamb, S, Kelly, C, Thickett, DR, Young, J, McAuley, D, Snaith, C, McCabe, C, Hulme, C, Gao Smith, F
التنسيق:	Journal article
منشور في:	2013

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus p... حسب Gates, S, Perkins, G, Lamb, S, Kelly, C, Thickett, DR, Young, J, McAuley, D, Snaith, C, McCabe, C, Hulme, C, Gao Smith, F

منشور في 2013

Journal article

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

مواد مشابهة